4.6

CiteScore

2.2

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Yan Li, Yi Jiang, Yicong Wan, Lin Zhang, Weiwei Tang, Jingjing Ma, Shan Wu, Wenjun Cheng. Medroxyprogestogen enhances apoptosis of SKOV-3 cells via inhibition of the PI3K/Akt signaling pathway[J]. The Journal of Biomedical Research, 2013, 27(1): 43-50. DOI: 10.7555/JBR.27.20120051
Citation: Yan Li, Yi Jiang, Yicong Wan, Lin Zhang, Weiwei Tang, Jingjing Ma, Shan Wu, Wenjun Cheng. Medroxyprogestogen enhances apoptosis of SKOV-3 cells via inhibition of the PI3K/Akt signaling pathway[J]. The Journal of Biomedical Research, 2013, 27(1): 43-50. DOI: 10.7555/JBR.27.20120051

Medroxyprogestogen enhances apoptosis of SKOV-3 cells via inhibition of the PI3K/Akt signaling pathway

Funds: 

This work was supported in part by the National Natural Science Foundation of China (No. 30772332), Jiangsu Province Health Department Program Grant (No. H200617), and Jiangsu Province Six Summit Talent Foundation (No. 303070774IB09).

More Information
  • Received Date: July 29, 2011
  • We sought to assess the effect of progestin on the apoptosis of epithelial ovarian cancer cell line SKOV-3 and via regulation of phosphorylation signaling in. Epithelial ovarian cancer cell line SKOV-3 was treated with me-droxyprogestogen, phosphatidylinositol 3-kinase inhibitor LY294002 and vehicle control. Akt, phospho-Akt, Bcl-2 and phospho-Bad proteins were examined by immunoblotting assays. Medroxyprogestogen-induced apoptosis was assessed by MTT assays and Annexin V apoptosis assay. We found no significant difference in Akt and Bad expression in both the medroxyprogestogen groups and the control group. The levels of phospho-Akt, Bcl-2 and phospho-Bad were decreased in all the medroxyprogestogen groups and significantly decreased in the high dose mitogen-activated protein (MAP) group (10 μmol/L). Viability of SKOV-3 was reduced and apparent apoptosis of SKOV-3 cells was observed with increased doses of MAP. The findings suggest that medroxyprogestogen can induce SKOV-3 cell apoptosis by inhibiting Akt phosphorylation.
  • Related Articles

    [1]Izzatullo Ziyoyiddin o`g`li Abdullaev, Ulugbek Gapparjanovich Gayibov, Sirojiddin Zoirovich Omonturdiev, Sobirova Fotima Azamjonovna, Sabina Narimanovna Gayibova, Takhir Fatikhovich Aripov. Molecular pathways in cardiovascular disease under hypoxia: Mechanisms, biomarkers, and therapeutic targets[J]. The Journal of Biomedical Research. DOI: 10.7555/JBR.38.20240387
    [2]Fangyuan Li, Yaohui Wang, Xiaochun Ping, Jiani C. Yin, Fufeng Wang, Xian Zhang, Xiang Li, Jing Zhai, Lizong Shen. Molecular evolution of intestinal-type early gastric cancer according to Correa cascade[J]. The Journal of Biomedical Research. DOI: 10.7555/JBR.38.20240118
    [3]Zheyue Wang, Qi Tang, Bende Liu, Wenqing Zhang, Yufeng Chen, Ningfei Ji, Yan Peng, Xiaohui Yang, Daixun Cui, Weiyu Kong, Xiaojun Tang, Tingting Yang, Mingshun Zhang, Xinxia Chang, Jin Zhu, Mao Huang, Zhenqing Feng. A SARS-CoV-2 neutralizing antibody discovery by single cell sequencing and molecular modeling[J]. The Journal of Biomedical Research, 2023, 37(3): 166-178. DOI: 10.7555/JBR.36.20220221
    [4]Misevic Gradimir. Single-cell omics analyses with single molecular detection: challenges and perspectives[J]. The Journal of Biomedical Research, 2021, 35(4): 264-276. DOI: 10.7555/JBR.35.20210026
    [5]Yuan Huang, Peng Quan, Yongwei Wang, Dongsheng Zhang, Mingwan Zhang, Rui Li, Nan Jiang. Host-guest interaction of β-cyclodextrin with isomeric ursolic acid and oleanolic acid: physicochemical characterization and molecular modeling study[J]. The Journal of Biomedical Research, 2017, 31(5): 395-407. DOI: 10.7555/JBR.31.20160073
    [6]Salam Pradeep Singh, Chitta Ranjan Deb, Sharif Udin Ahmed, Yenisetti Saratchandra, Bolin Kumar Konwar. Molecular docking simulation analysis of the interaction of dietary flavonols with heat shock protein 90[J]. The Journal of Biomedical Research, 2016, 30(1): 67-74. DOI: 10.7555/JBR.30.20130158
    [7]Usman Sumo Friend Tambunan, Rizky Archintya Rachmania, Arli Aditya Parikesit. In silico modification of oseltamivir as neuraminidase inhibitor of influenza A virus subtype H1N1[J]. The Journal of Biomedical Research, 2015, 29(2): 150-159. DOI: 10.7555/JBR.29.20130024
    [8]Talambedu Usha, Sushil Kumar Middha, Arvind Kumar Goyal, Mahesh Karthik, DA Manoj, Syed Faizan, Peyush Goyal, HP Prashanth, Veena Pande. Molecular docking studies of anti-cancerous candidates in Hippophae rhamnoides and Hippophae salicifolia[J]. The Journal of Biomedical Research, 2014, 28(5): 406-415. DOI: 10.7555/JBR.28.20130110
    [9]Meilin Wang, Haiyan Chu, Zhengdong Zhang, Qingyi Wei. Molecular epidemiology of DNA repair gene polymorphisms and head and neck cancer[J]. The Journal of Biomedical Research, 2013, 27(3): 179-192. DOI: 10.7555/JBR.27.20130034
    [10]Daniel G Rosen, Zhihong Zhang, Weiwei Shan, Jinsong Liu. Morphological and molecular basis of ovarian serous carcinoma[J]. The Journal of Biomedical Research, 2010, 24(4): 257-263. DOI: 10.1016/S1674-8301(10)60036-X
  • Cited by

    Periodical cited type(15)

    1. Antonelli R, Forconi V, Molesti E, et al. A validated and standardized pseudotyped microneutralization assay as a safe and powerful tool to measure LASSA virus neutralising antibodies for vaccine development and comparison. F1000Res, 2024, 13: 534. DOI:10.12688/f1000research.149578.2
    2. Nahar N, Nazmul Hasan Zilani M, Biswas P, et al. Profiling of secondary metabolite and evaluation of anti-diabetic potency of Crotalaria quinquefolia (L): In-vitro, in-vivo, and in-silico approaches. Saudi Pharm J, 2024, 32(1): 101887. DOI:10.1016/j.jsps.2023.101887
    3. Nur Kabidul Azam M, Biswas P, Mohaimenul Islam Tareq M, et al. Identification of antidiabetic inhibitors from Allophylus villosus and Mycetia sinensis by targeting α-glucosidase and PPAR-γ: In-vitro, in-vivo, and computational evidence. Saudi Pharm J, 2024, 32(1): 101884. DOI:10.1016/j.jsps.2023.101884
    4. Rahman MH, Al Azad S, Uddin MF, et al. WGS-based screening of the co-chaperone protein DjlA-induced curved DNA binding protein A (CbpA) from a new multidrug-resistant zoonotic mastitis-causing Klebsiella pneumoniae strain: a novel molecular target of selective flavonoids. Mol Divers, 2023. DOI:10.1007/s11030-023-10731-6. Online ahead of print
    5. Akash S, Bibi S, Biswas P, et al. Revolutionizing anti-cancer drug discovery against breast cancer and lung cancer by modification of natural genistein: an advanced computational and drug design approach. Front Oncol, 2023, 13: 1228865. DOI:10.3389/fonc.2023.1228865
    6. Sharif MA, Khan AM, Salekeen R, et al. Phyllanthus emblica (Amla) methanolic extract regulates multiple checkpoints in 15-lipoxygenase mediated inflammopathies: Computational simulation and in vitro evidence. Saudi Pharm J, 2023, 31(8): 101681. DOI:10.1016/j.jsps.2023.06.014
    7. Biswas P, Bibi S, Yousafi Q, et al. Study of MDM2 as Prognostic Biomarker in Brain-LGG Cancer and Bioactive Phytochemicals Inhibit the p53-MDM2 Pathway: A Computational Drug Development Approach. Molecules, 2023, 28(7): 2977. DOI:10.3390/molecules28072977
    8. Jabin A, Uddin MF, Al Azad S, et al. Target-specificity of different amyrin subunits in impeding HCV influx mechanism inside the human cells considering the quantum tunnel profiles and molecular strings of the CD81 receptor: a combined in silico and in vivo study. In Silico Pharmacol, 2023, 11(1): 8. DOI:10.1007/s40203-023-00144-6
    9. Arefin A, Gage MC. Metformin, Empagliflozin, and Their Combination Modulate Ex-Vivo Macrophage Inflammatory Gene Expression. Int J Mol Sci, 2023, 24(5): 4785. DOI:10.3390/ijms24054785
    10. Morshed AKMH, Al Azad S, Mia MAR, et al. Oncoinformatic screening of the gene clusters involved in the HER2-positive breast cancer formation along with the in silico pharmacodynamic profiling of selective long-chain omega-3 fatty acids as the metastatic antagonists. Mol Divers, 2023, 27(6): 2651-2672. DOI:10.1007/s11030-022-10573-8
    11. Dey D, Biswas P, Paul P, et al. Natural flavonoids effectively block the CD81 receptor of hepatocytes and inhibit HCV infection: a computational drug development approach. Mol Divers, 2023, 27(3): 1309-1322. DOI:10.1007/s11030-022-10491-9
    12. Islam S, Farjana M, Uddin MR, et al. Molecular identification, characterization, and antagonistic activity profiling of Bacillus cereus LOCK 1002 along with the in-silico analysis of its presumptive bacteriocins. J Adv Vet Anim Res, 2022, 9(4): 663-675. DOI:10.5455/javar.2022.i635
    13. Biswas P, Dey D, Biswas PK, et al. A Comprehensive Analysis and Anti-Cancer Activities of Quercetin in ROS-Mediated Cancer and Cancer Stem Cells. Int J Mol Sci, 2022, 23(19): 11746. DOI:10.3390/ijms231911746
    14. Ferdausi N, Islam S, Rimti FH, et al. Point-specific interactions of isovitexin with the neighboring amino acid residues of the hACE2 receptor as a targeted therapeutic agent in suppressing the SARS-CoV-2 influx mechanism. J Adv Vet Anim Res, 2022, 9(2): 230-240. DOI:10.5455/javar.2022.i588
    15. Dey D, Hasan MM, Biswas P, et al. Investigating the Anticancer Potential of Salvicine as a Modulator of Topoisomerase II and ROS Signaling Cascade. Front Oncol, 2022, 12: 899009. DOI:10.3389/fonc.2022.899009

    Other cited types(0)

Catalog

    Article Metrics

    Article views (5062) PDF downloads (1293) Cited by(15)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return